Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $765.75 billion, total revenue of $166.26 billion and a weighted average PE ratio of 51.45.
Market Cap
765.75B
Revenue
166.26B
Profits
14.88B
PE Ratio
51.45
Profit Margin
8.95%
Dividend Yield
0.19%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 216.42B | 1.56% | 1,906,792 | 43.74B |
| 2 | DHR | Danaher Corporation | 159.29B | 2.30% | 5,298,074 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 53.52B | 0.18% | 574,096 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 40.78B | -0.47% | 2,299,640 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 37.00B | 0.54% | 1,134,647 | 15.90B |
| 6 | NTRA | Natera, Inc. | 29.49B | 3.69% | 2,138,585 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.53B | 0.54% | 161,515 | 3.94B |
| 8 | WAT | Waters Corporation | 22.42B | -0.36% | 445,989 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.54B | -0.60% | 607,081 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.62B | -0.47% | 1,368,388 | 10.85B |
| 11 | ILMN | Illumina, Inc. | 18.64B | 1.57% | 1,497,361 | 4.29B |
| 12 | MEDP | Medpace Holdings, Inc. | 16.62B | 0.75% | 219,068 | 2.36B |
| 13 | EXAS | Exact Sciences Corporation | 13.20B | 3.77% | 3,461,498 | 3.08B |
| 14 | ICLR | ICON Public Limited Company | 12.30B | 2.89% | 567,711 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 12.05B | -0.94% | 1,527,887 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 10.55B | 2.20% | 837,401 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.62B | 0.50% | 1,357,548 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 8.00B | -0.13% | 1,273,023 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 6.11B | 2.75% | 827,347 | 1.97B |
| 20 | BLLN | BillionToOne, Inc. | 4.44B | 6.41% | 117,646 | 209.03M |
| 21 | SHC | Sotera Health Company | 4.33B | -0.20% | 2,169,055 | 1.15B |
| 22 | WGS | GeneDx Holdings Corp. | 3.67B | -2.03% | 255,946 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.18B | -4.10% | 1,986,064 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.06B | -1.32% | 1,671,838 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.59B | -1.74% | 2,694,693 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.35B | 1.86% | 2,980,085 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.29B | -7.79% | 3,704,523 | 886.89M |
| 28 | OPK | OPKO Health, Inc. | 982.66M | 0.79% | 2,341,122 | 642.07M |
| 29 | CSTL | Castle Biosciences, Inc. | 979.28M | -1.18% | 329,737 | 343.53M |
| 30 | FLGT | Fulgent Genetics, Inc. | 899.55M | 1.01% | 263,126 | 315.55M |
| 31 | CDNA | CareDx, Inc | 810.58M | 1.61% | 631,551 | 358.00M |
| 32 | PSNL | Personalis, Inc. | 676.69M | 1.87% | 1,004,286 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 619.41M | -0.45% | 1,194,665 | 825.30M |
| 34 | XGN | Exagen Inc. | 186.06M | -3.07% | 289,205 | 63.60M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 181.45M | -5.52% | 69,682 | 4.40M |
| 36 | PRE | Prenetics Global Limited | 166.15M | 4.16% | 70,717 | 77.08M |
| 37 | MDXH | MDxHealth SA | 158.89M | - | 402,647 | 103.07M |
| 38 | BNR | Burning Rock Biotech Limited | 154.39M | -6.15% | 11,649 | 74.86M |
| 39 | FONR | FONAR Corporation | 93.55M | -0.76% | 20,834 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 57.16M | -9.28% | 230,486 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 37.45M | 9.96% | 34,807 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 29.46M | 24.62% | 11,608,819 | 505.30M |
| 43 | BNBX | Applied DNA Sciences, Inc. | 12.02M | 0.36% | 48,502 | 3.74M |
| 44 | PRPH | ProPhase Labs, Inc. | 10.72M | -2.57% | 554,803 | 5.59M |
| 45 | CHEK | Check-Cap Ltd. | 9.19M | -15.59% | 143,795 | - |
| 46 | ADVB | Advanced Biomed Inc. | 8.95M | 0.15% | 79,192 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 6.60M | -6.96% | 103,930 | 6.78M |
| 48 | MYNZ | Mainz Biomed N.V. | 6.50M | -4.76% | 1,353,689 | 659.94K |
| 49 | ISPC | iSpecimen Inc. | 5.42M | -4.50% | 181,387 | 3.35M |
| 50 | XWEL | XWELL, Inc. | 5.18M | -3.12% | 49,010 | 29.52M |
| 51 | NDRA | ENDRA Life Sciences Inc. | 5.04M | 7.90% | 19,773 | - |